View Full Version : Sales of drug Zelmac stopped in Spore

04-04-2007, 08:55 AM
The Spore Health Sciences Authority has temporarily withheld sales of Zelmac, a drug used to treat IBS (irritable bowel syndrome) in women, as it has been linked to an increased risk of heart attacks and strokes.

The decision was made after the US FDA pulled the drug from the US market.

However, a report in the Spore Straits Times (http://straitstimes.asia1.com.sg) today quoted Dr Gwee Kok Ann (a consultant gastroenterologist at Gleneagles Medical Centre) as saying that for patients with low risk of heart disease, the benefits of Zelmac outweigh the risks.

It also quoted Dr Law Ngai Moh (a consultant gastroenterologist at Raffles Hospital) as saying that the problems occurred in those who were taking Zelmac regularly on a long-term basis and that most patients in Spore take it only intermittently for relief of IBS symptoms such as abdominal bloating and constipation.